EnerSys amended its tender offer statement for Ultralife, offering $16.00 per share in cash. The offer expires at 5:00 p.m., New York City time, on December 3, 2026, unless extended or earlier terminated under the Merger Agreement.
ENS · EnerSys
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
EnerSys reported $950 million net sales and, excluding tariff refunds, $154 million adjusted operating earnings and $3.26 adjusted diluted EPS; it agreed to acquire Ultralife at an enterprise value of approximately $320 million.
EnerSys reported second-quarter fiscal 2027 net sales of $949.9 million, diluted EPS of $2.42 and adjusted diluted EPS of $3.22. Its board declared a $0.2875 per-share dividend payable December 31, 2026, to holders of record December 18, 2026.
EnerSys proposes to acquire Ultralife for $16.00 per share in cash, valuing it at approximately $320 million and expecting closure in the first quarter of calendar year 2027. Six-month fiscal 2027 gross profit rose $67.4 million, or 12.7%.
EnerSys, via EnerSys Mergersub Inc., is offering $16.00 per share in cash for all outstanding Ultralife Corporation shares, with the offer expiring December 3, 2026 unless extended. It has no financing condition and would make Ultralife a wholly owned subsidiary.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY27 earnings call · Nov 12, 2026TL;DR. EnerSys delivered gross-margin and EPS growth, strong PPS and NIS performance, higher orders and backlog, and increased fiscal-year-to-date free cash flow, while the proposed Ultralife acquisition is expected to add synergies and EPS accretion. Sales missed guidance, IMS remained pressured by material-handling softness and unfavorable mix, and Q3 faces margin headwinds from mix, tough comparisons, and freight and commodity inflation.
- + Gross margin expanded to 29.9% (25.2% ex-IRC 45X), while diluted EPS rose 34% to $2.42. new
- + PPS revenue rose 21%, with adjusted operating earnings up 43% and adjusted operating margin up 340 basis points. new
- + NIS revenue rose 3%, while adjusted operating earnings increased 38% and adjusted operating margin expanded 290 basis points. new
- + Orders rose 21% year over year, backlog increased 36%, and book-to-bill reached 1.09. new
- + Fiscal-year-to-date free cash flow increased to $348.0 million from $165.1 million. new
- + The proposed Ultralife acquisition is expected to generate approximately $15 million to $20 million of annual run-rate cost synergies and adjusted EPS accretion within 18 months of closing. new
- − Second-quarter net sales were below guidance and decreased 0.1% year over year. new
- − IMS revenue fell 8%, adjusted operating earnings declined 13%, and adjusted operating margin contracted 60 basis points. new
- − Material handling orders declined by a lower single-digit percentage year over year amid an uncertain recovery. new
- − Third-quarter IMS margins are expected to face pressure as transportation grows faster than higher-margin material handling. new
- − PPS and NIS face tough prior-year margin comparisons due to project timing and quarterly fluctuations. new
- − Freight and commodity inflation increased and may take a quarter to recover through pricing. new
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS (Non-GAAP)(1) non-GAAP | $6.88 | Six months of fiscal 2027 | — |
| adjusted diluted EPS ex IRC 45X non-GAAP | $2.02 | Second quarter of fiscal 2027 | — |
| Adjusted EBITDA (non-GAAP) per credit agreement non-GAAP | 697.6M | Last twelve months ended 10/4/2026 | — |
| Adjusted EBITDA (Non-GAAP)(3) non-GAAP | $365.6M | Six months of fiscal 2027 | — |
|
|
|||
| Adjusted Gross Profit non-GAAP | 598.9M | Six months ended 10/4/2026 | — |
| Adjusted Operating Earnings (Non-GAAP)(2) non-GAAP | $331.2M | Six months of fiscal 2027 | — |
|
|
|||
| Capital expenditures | $12.4M | Second quarter of fiscal 2027 | -40.7% |
|
|
|||
| cash from operating activities | $372.8M | Six months of fiscal 2027 | — |
| Dividends per common share | $0.29 | Quarter ended 10/4/2026 | — |
|
|
|||
| EBITDA (non-GAAP) non-GAAP | 608.6M | Last twelve months ended 10/4/2026 | — |
| EBITDA (Non-GAAP)(3) non-GAAP | $317.7M | Six months of fiscal 2027 | — |
|
|
|||
| Free Cash Flow | 130.4M | Quarter ended 10/4/2026 | — |
|
|
|||
| Free cash flow conversion % | 145.6% | Quarter ended 10/4/2026 | — |
|
|
|||
| GM ex IRC 45X non-GAAP | 25.2% | Second quarter of fiscal 2027 | — |
|
|
|||
| Gross Margin (GM) | 29.9% | Second quarter of fiscal 2027 | — |
| Gross Profit ex 45X non-GAAP | 506.2M | Six months ended 10/4/2026 | — |
|
|
|||
| net debt | $554.9M | As of October 4, 2026 | — |
| Non-GAAP adjusted Net earnings non-GAAP | 118.9M | Quarter ended 10/4/2026 | — |
|
|
|||
| Non-GAAP adjusted Net earnings excluding (ex) IRC 45X benefit non-GAAP | 74.5M | Quarter ended 10/4/2026 | — |
| Non-GAAP adjusted Net Earnings without IRC 45X non-GAAP | 165M | Six months ended 10/4/2026 | — |
| Operating cash flow conversion % | 159.4% | Quarter ended 10/4/2026 | — |
|
|
|||
| quarterly cash dividend | $0.29 | Third Quarter of Fiscal Year 2027 | — |
|
|
|||
| quarterly dividend payment | $10.3M | second quarter | — |
| Share Repurchases | $180M | Six months of fiscal 2027 | — |
|
|
|||
| Total Capital Returned to Stockholders | $199.9M | Six months of fiscal 2027 | — |
|
|
|||
| Total net debt non-GAAP | 554.9M | Last twelve months ended 10/4/2026 | — |
| Total net debt/credit adjusted EBITDA ratio non-GAAP | 0.8 | Last twelve months ended 10/4/2026 | — |
|
|
|||
| Total Non-GAAP adjustments non-GAAP | 36.2M | Quarter ended 10/4/2026 | — |
| Adjusted Operating Margin non-GAAP | 19.1% | Quarter ended July 5, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Electrical Equipment & Parts — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ENS
this stock
EnerSys
|
$5.09B | -2.6% | +15.8% | 14.4 | 7.2% |
|
CYATY
Contemporary Amperex Technology Co., Limited
|
$216.19B | — | — | — | 0.0% |
|
ABLZF
Abb Ltd
|
$149.44B | +7.9% | +9.5% | — | 0.2% |
|
VRT
Vertiv Holdings Co
|
$77.81B | +24.7% | +27.7% | 37.8 | 2.9% |
|
BE
Bloom Energy Corp
|
$56.76B | +121.0% | +37.3% | 117.1 | 6.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 13, 2026
- This year
- 24
EnerSys amended its tender offer statement for Ultralife, offering $16.00 per share in cash. The offer expires at 5:00 p.m., New York City time, on December 3, 2026, unless extended or earlier terminated under the Merger Agreement.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ENS | -2.7% | -15.2% | -41.2% | -10.6% | -2.6% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -5.3% | -14.1% | -41.7% | -10.4% | -13.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.